Skip to Content

Cancers, Volume 14, Issue 21

2022 November-1 - 301 articles

Cover Story: Complementary and alternative medicine (CAM) therapies include a wide range of procedures and products that are often used by cancer patients to directly combat cancer and protect normal cells from the toxic effects of conventional therapies. Most often, their use is self-prescribed, based on a collection of scattered information from websites and advice from relatives or friends, possibly leading to unexpected toxicities and a reduction in the efficacy of cancer therapy. Despite claims of promising and potential benefits made by prescribers, many CAMs lack clear scientific evidence of their safety and efficacy. Given the widespread use of CAM, in this review we focused on the most important known data on the interaction risk between anticancer drugs and CAMs in accordance with the meaning of integrative medicine, providing a practical guide for caregivers and patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (301)

  • Review
  • Open Access
12 Citations
8,103 Views
28 Pages

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

  • Sara Sánchez-Molina,
  • Elisabet Figuerola-Bou,
  • Víctor Sánchez-Margalet,
  • Luis de la Cruz-Merino and ,
  • Jaume Mora,
  • Enrique de Álava Casado,
  • Daniel José García-Domínguez and
  • Lourdes Hontecillas-Prieto
  • + 3 authors+ 0 author

7 November 2022

Ewing Sarcoma (EWS) is an aggressive bone and soft tissue tumor that mainly affects children, adolescents, and young adults. The standard therapy, including chemotherapy, surgery, and radiotherapy, has substantially improved the survival of EWS patie...

(This article belongs to the Special Issue Ewing Sarcoma: Basic Biology, Clinical Challenges and Future Perspectives)
  • Review
  • Open Access
26 Citations
4,108 Views
22 Pages

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?

  • Amandine Badie,
  • Christian Gaiddon and
  • Georg Mellitzer

7 November 2022

Gastric cancer (GC) is one of the most aggressive cancers. Therapeutic treatments are based on surgery combined with chemotherapy using a combination of platinum-based agents. However, at metastatic stages of the disease, survival is extremely low du...

  • Review
  • Open Access
7 Citations
4,624 Views
13 Pages

Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma

  • Ane Amundarain,
  • Fernando Pastor,
  • Felipe Prósper and
  • Xabier Agirre

7 November 2022

Multiple Myeloma (MM) remains an incurable disease due to high relapse rates and fast development of drug resistances. The introduction of monoclonal antibodies (mAb) has caused a paradigm shift in MM treatment, paving the way for targeted approaches...

(This article belongs to the Special Issue Aptamers and Cancer)
  • Systematic Review
  • Open Access
47 Citations
4,848 Views
12 Pages

The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

  • Caterina Caminiti,
  • Giuseppe Maglietta,
  • Francesca Diodati,
  • Matteo Puntoni and ,
  • Barbara Marcomini,
  • Silvia Lazzarelli,
  • Carmine Pinto and
  • Francesco Perrone
  • + 3 authors+ 0 author

7 November 2022

This study examined the effects of the routine assessment of patient-reported outcomes (PROs) on the overall survival of adult patients with cancer. We included clinical trials and observational studies with a control group that compared PRO monitori...

(This article belongs to the Special Issue Quality of Life and Side Effects Management in Cancer Treatment)
  • Article
  • Open Access
9 Citations
3,019 Views
9 Pages

Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

  • Viola K. DeTemple,
  • Jessica C. Hassel,
  • Michael M. Sachse,
  • Imke Grimmelmann and ,
  • Ulrike Leiter,
  • Christoffer Gebhardt,
  • Julia Eckardt,
  • Claudia Pföhler,
  • Yenny Angela and
  • Ralf Gutzmer
  • + 6 authors+ 1 author

7 November 2022

For patients with advanced basal cell carcinoma (aBCC) first-line treatment with hedgehog inhibitors (HHIs) and second-line treatment with PD1 inhibitors (PD1i) is available, offering combination and sequencing options. Here, we focus on the efficacy...

(This article belongs to the Special Issue Skin Cancer: Epidemiology, Prevention and Quality of Life)
  • Review
  • Open Access
15 Citations
11,059 Views
18 Pages

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer

  • Elisa Agostinetto,
  • Flavia Jacobs,
  • Véronique Debien,
  • Alex De Caluwé and ,
  • Catalin-Florin Pop,
  • Xavier Catteau,
  • Philippe Aftimos,
  • Evandro de Azambuja and
  • Laurence Buisseret
  • + 4 authors+ 0 author

7 November 2022

Pre-surgical treatments in patients with early breast cancer allows a direct estimation of treatment efficacy, by comparing the tumor and the treatment. Patients who achieve a pathological complete response at surgery have a better prognosis, with lo...

(This article belongs to the Special Issue Post-neoadjuvant Strategies in Breast Cancer)
  • Review
  • Open Access
51 Citations
9,950 Views
26 Pages

7 November 2022

Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide due to its high rates of tumor recurrence and metastasis. Aberrant Wnt/β-catenin signaling has been shown to play a significant role in HCC development, progression and cl...

(This article belongs to the Section Cancer Pathophysiology)
  • Systematic Review
  • Open Access
25 Citations
6,608 Views
16 Pages

7 November 2022

Awake craniotomy with direct electrical stimulation (DES) is the standard treatment for patients with gliomas in eloquent areas. Even though language is monitored carefully during surgery, many patients suffer from postoperative aphasia, with negativ...

(This article belongs to the Special Issue Advances of Brain Mapping in Cancer Research)
  • Article
  • Open Access
5 Citations
2,833 Views
18 Pages

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System

  • Niklas Gebauer,
  • Maria Ziehm,
  • Judith Gebauer,
  • Armin Riecke and ,
  • Sebastian Meyhöfer,
  • Birte Kulemann,
  • Nikolas von Bubnoff,
  • Konrad Steinestel,
  • Arthur Bauer and
  • Hanno M. Witte
  • + 5 authors+ 0 author

7 November 2022

Background: Across a variety of solid tumors, prognostic implications of nutritional and inflammation-based risk scores have been identified as a complementary resource of risk stratification. Methods: In this retrospective study, we performed a comp...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Systematic Review
  • Open Access
13 Citations
4,373 Views
19 Pages

Anastomotic Leak in Ovarian Cancer Cytoreduction Surgery: A Systematic Review and Meta-Analysis

  • Massimiliano Fornasiero,
  • Georgios Geropoulos,
  • Konstantinos S. Kechagias,
  • Kyriakos Psarras and ,
  • Konstantinos Katsikas Triantafyllidis,
  • Panagiotis Giannos,
  • Georgios Koimtzis,
  • Nikoletta A. Petrou,
  • James Lucocq and
  • Dimitrios Giannis
  • + 6 authors+ 1 author

7 November 2022

Introduction: Anastomotic leaks (AL) following ovarian cytoreduction surgery could be detrimental, leading to significant delays in commencing adjuvant chemotherapy, prolonged hospital stays and increased morbidity. The aim of this study was to inves...

(This article belongs to the Special Issue Systematic Reviews and Meta-Analyses of Genitourinary Cancers)
  • Article
  • Open Access
5 Citations
3,316 Views
14 Pages

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

  • Rie von Eyben,
  • Daniel S. Kapp,
  • Manuela Andrea Hoffmann,
  • Cigdem Soydal and ,
  • Christian Uprimny,
  • Irene Virgolini,
  • Murat Tuncel,
  • Mathieu Gauthé and
  • Finn E. von Eyben
  • + 4 authors+ 0 author

7 November 2022

An individual patient meta-analysis followed 1216 patients with PSA-only recurrence (biochemical recurrence, BCR) restaged with [68Ga]Ga-PSMA-11 PET/CT before the salvage treatment for median 3.5 years and analyzed the overall survival (OS). A new ri...

(This article belongs to the Special Issue Prostate-Specific Membrane Antigen (PSMA))
  • Article
  • Open Access
5 Citations
3,874 Views
14 Pages

Enhanced Recovery after Uterine Corpus Cancer Surgery: A 10 Year Retrospective Cohort Study of Robotic Surgery in an NHS Cancer Centre

  • Christina Uwins,
  • Radwa Hablase,
  • Hasanthi Assalaarachchi,
  • Anil Tailor and ,
  • Alexandra Stewart,
  • Jayanta Chatterjee,
  • Patricia Ellis,
  • Simon S. Skene,
  • Agnieszka Michael and
  • Simon Butler-Manuel
  • + 5 authors+ 0 author

7 November 2022

Royal Surrey NHS Foundation Trust introduced robotic surgery for uterine corpus cancer in 2010 to support increased access to minimally invasive surgery, a central element of an enhanced recovery after surgery (ERAS) pathway. More than 1750 gynaecolo...

(This article belongs to the Special Issue Gynaecological Cancer and Surgery: Current Practice, Novel Technologies and Future Developments)
  • Feature Paper
  • Review
  • Open Access
44 Citations
7,776 Views
22 Pages

7 November 2022

Breast cancer (BC) is well-known for being a leading cause of death worldwide. It is classified molecularly into luminal A, luminal B HER2−, luminal B HER2+, HER2+, and triple-negative breast cancer (TNBC). These subtypes differ in their progno...

(This article belongs to the Special Issue Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion)
  • Article
  • Open Access
40 Citations
4,908 Views
13 Pages

Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma

  • Gregory Baud,
  • Arnaud Jannin,
  • Camille Marciniak,
  • Benjamin Chevalier and ,
  • Christine Do Cao,
  • Emmanuelle Leteurtre,
  • Amandine Beron,
  • Georges Lion,
  • Samuel Boury and
  • François Pattou
  • + 9 authors+ 4 authors

7 November 2022

Background: Lymph node dissection (LND) in primary treatment of differentiated thyroid carcinoma is controversial. The aim of our retrospective study was to analyse the risk factors of post-thyroidectomy complications and to assess the morbidity of l...

(This article belongs to the Special Issue Management and Treatment of Endocrine Tumors)
  • Article
  • Open Access
6 Citations
3,075 Views
13 Pages

Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study

  • Masaki Kaibori,
  • Kengo Yoshii,
  • Hisashi Kosaka,
  • Masato Ota and ,
  • Koji Komeda,
  • Masaki Ueno,
  • Daisuke Hokutou,
  • Hiroya Iida,
  • Kosuke Matsui and
  • Mitsugu Sekimoto
  • + 5 authors+ 0 author

7 November 2022

Accurate risk stratification selects patients who are expected to benefit most from surgery. This retrospective study enrolled 225 Japanese patients with intrahepatic cholangiocellular carcinoma (ICC) who underwent hepatectomy between January 2009 an...

(This article belongs to the Collection Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma)
  • Review
  • Open Access
20 Citations
4,116 Views
18 Pages

Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease

  • Magda Zanelli,
  • Paola Parente,
  • Francesca Sanguedolce,
  • Maurizio Zizzo and ,
  • Andrea Palicelli,
  • Alessandra Bisagni,
  • Illuminato Carosi,
  • Domenico Trombetta,
  • Luca Mastracci and
  • Stefano Ascani
  • + 11 authors+ 6 authors

6 November 2022

Intravascular lymphoma is a form of lymphoid malignancy characterized by neoplastic cells growing almost exclusively within the lumina of small- to medium-sized blood vessels. Most cases are of B-cell origin with rare cases of natural killer or T-cel...

  • Article
  • Open Access
180 Citations
23,732 Views
18 Pages

An Effective Method for Lung Cancer Diagnosis from CT Scan Using Deep Learning-Based Support Vector Network

  • Imran Shafi,
  • Sadia Din,
  • Asim Khan,
  • Isabel De La Torre Díez and ,
  • Ramón del Jesús Palí Casanova,
  • Kilian Tutusaus Pifarre and
  • Imran Ashraf
  • + 2 authors+ 0 author

6 November 2022

The diagnosis of early-stage lung cancer is challenging due to its asymptomatic nature, especially given the repeated radiation exposure and high cost of computed tomography(CT). Examining the lung CT images to detect pulmonary nodules, especially th...

  • Review
  • Open Access
39 Citations
6,845 Views
22 Pages

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer

  • Xiaolu Sun,
  • Kuai Liu,
  • Shuli Lu,
  • Weina He and
  • Zixiu Du

6 November 2022

Breast cancer (BC) is the most common malignancy in women worldwide, and it is a molecularly diverse disease. Heterogeneity can be observed in a wide range of cell types with varying morphologies and behaviors. Molecular classifications are broadly u...

  • Article
  • Open Access
12 Citations
9,294 Views
10 Pages

Recurrence of Oral Leukoplakia after CO2 Laser Resection: A Prospective Longitudinal Study

  • Adela Rodriguez-Lujan,
  • Pia López-Jornet and
  • Eduardo Pons-Fuster López

6 November 2022

Aim: The aim of this study is to assess the efficacy of CO2 laser treatment in oral leukoplakia and to analyse the recurrence rate of oral leukoplakia lesions at 18-month follow-up. Materials and methods: A prospective clinical study regarding CO2 la...

  • Article
  • Open Access
13 Citations
4,153 Views
15 Pages

6 November 2022

Cancer cells may stimulate glycolytic flux when O2 becomes insufficient. Increase in L-lactate release therefore appears as an escape mechanism to drugs targeting mitochondrial respiration but also represents a response that may be exploited to scree...

  • Article
  • Open Access
7 Citations
3,440 Views
19 Pages

CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3

  • Lucas Porras,
  • Faustine Gorse,
  • Ndeye Khady Thiombane,
  • Louis Gaboury and
  • Sylvie Mader

6 November 2022

Estrogen receptor alpha (ERα) expression in ~2/3 breast tumors selects patients for hormonal therapies. Tumors negative for ERα but positive for the progesterone receptor (PR, encoded by PGR) have also been candidates for ER-targeting the...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
26 Citations
4,384 Views
16 Pages

Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee

  • Alexandra Masson-Lecomte,
  • Victoire Vaillant,
  • Mathieu Roumiguié,
  • Stéphan Lévy and ,
  • Benjamin Pradère,
  • Michaël Peyromaure,
  • Igor Duquesne,
  • Alexandre De La Taille,
  • Cédric Lebâcle and
  • Yann Neuzillet
  • + 15 authors+ 10 authors

6 November 2022

Upper urinary tract urothelial carcinoma (UTUC) is an uncommon disease and its gold-standard treatment is radical nephroureterectomy (RNU). Distal ureterectomy (DU) might be an alternative for tumors of the distal ureter but its indications remain un...

(This article belongs to the Special Issue Advance and New Insights in Bladder Cancer)
  • Article
  • Open Access
33 Citations
5,324 Views
20 Pages

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors

  • Walid Shalata,
  • Sarah Weissmann,
  • Sapir Itzhaki Gabay,
  • Kim Sheva and ,
  • Omar Abu Saleh,
  • Ashraf Abu Jama,
  • Alexander Yakobson and
  • Keren Rouvinov
  • + 3 authors+ 0 author

5 November 2022

Immune checkpoint inhibitors are a class of cancer treatment drugs that stimulate the immune system’s ability to fight tumor cells. These drugs are monoclonal antibodies targeting im-mune-inhibiting proteins on cancer cells, such as CTLA-4 and...

(This article belongs to the Special Issue Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?)
  • Article
  • Open Access
9 Citations
5,496 Views
18 Pages

5 November 2022

BRAF V600E mutation drives uncontrolled cell growth in most melanomas. While BRAF V600E tumors are initially responsive to BRAF inhibitors, prolonged treatment results in inhibitor resistance and tumor regrowth. Clinical data have linked the NRAS Q61...

(This article belongs to the Special Issue Targeting the (Un)Usual Suspects in Cancer)
  • Review
  • Open Access
18 Citations
4,645 Views
13 Pages

Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment

  • Marie Rajtmajerová,
  • Andriy Trailin,
  • Václav Liška,
  • Kari Hemminki and
  • Filip Ambrozkiewicz

5 November 2022

As the current staging and grading systems are not sufficient to stratify patients for therapy and predict the outcome of the disease, there is an urgent need to understand cancer in its complexity. The mutual relationship between tumour and immune o...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
27 Citations
4,542 Views
23 Pages

Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates—A Comprehensive Statistical Analysis

  • Klaus-Peter Dieckmann,
  • Hendrik Isbarn,
  • Francesca Grobelny,
  • Cansu Dumlupinar and ,
  • Julia Utschig,
  • Christian Wülfing,
  • Uwe Pichlmeier and
  • Gazanfer Belge
  • + 3 authors+ 0 author

5 November 2022

The role of primary tumour size (TS) in the clinical course of testicular tumours is incompletely understood. We retrospectively evaluated 641 consecutive patients with testicular neoplasms with regard to TS, histology, clinical stage (CS), serum tum...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
31 Citations
4,693 Views
15 Pages

Prostate Cancer Stem Cells: The Role of CD133

  • Jianhui Yang,
  • Omar Aljitawi and
  • Peter Van Veldhuizen

5 November 2022

Prostate cancer stem cells (PCSCs), possessing self-renewal properties and resistance to anticancer treatment, are possibly the leading cause of distant metastasis and treatment failure in prostate cancer (PC). CD133 is one of the most well-known and...

(This article belongs to the Special Issue Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment)
  • Article
  • Open Access
3 Citations
4,220 Views
18 Pages

Water-Soluble Truncated Fatty Acid–Porphyrin Conjugates Provide Photo-Sensitizer Activity for Photodynamic Therapy in Malignant Mesothelioma

  • Sam Bonsall,
  • Simeon Hubbard,
  • Uthaman Jithin,
  • Joseph Anslow and ,
  • Dylan Todd,
  • Callum Rowding,
  • Tom Filarowski,
  • Greg Duly,
  • Ryan Wilson and
  • Sarah Haywood-Small
  • + 7 authors+ 2 authors

5 November 2022

Clinical trials evaluating intrapleural photodynamic therapy (PDT) are ongoing for mesothelioma. Several issues still hinder the development of PDT, such as those related to the inherent properties of photosensitizers. Herein, we report the synthesis...

(This article belongs to the Special Issue Recent Research on Mesothelioma)
  • Article
  • Open Access
23 Citations
4,507 Views
14 Pages

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy

  • Ekaterina Mikhailova,
  • Olga Illarionova,
  • Alexander Komkov,
  • Elena Zerkalenkova and ,
  • Ilgar Mamedov,
  • Larisa Shelikhova,
  • Yulia Olshanskaya,
  • Natalia Miakova,
  • Galina Novichkova and
  • Alexander Popov
  • + 7 authors+ 2 authors

5 November 2022

We aimed to develop an antibody panel and data analysis algorithm for multicolor flow cytometry (MFC), which is a reliable method for minimal residual disease (MRD) detection in patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) tr...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
104 Citations
17,703 Views
22 Pages

Classic and New Markers in Diagnostics and Classification of Breast Cancer

  • Roman Beňačka,
  • Daniela Szabóová,
  • Zuzana Guľašová,
  • Zdenka Hertelyová and
  • Jozef Radoňák

5 November 2022

Breast cancer remains the most frequently diagnosed form of female’s cancer, and in recent years it has become the most common cause of cancer death in women worldwide. Like many other tumours, breast cancer is a histologically and biologically...

(This article belongs to the Special Issue Breast Cancer: Novel Histological and Molecular Markers for Diagnosis, Prognosis, Therapeutic Prediction, and Drug Resistance)
  • Review
  • Open Access
29 Citations
5,328 Views
20 Pages

Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies

  • Camille Sauter,
  • John Simonet,
  • Fabien Guidez,
  • Baptiste Dumétier and ,
  • Baptiste Pernon,
  • Mary Callanan,
  • Jean-Noël Bastie,
  • Romain Aucagne and
  • Laurent Delva
  • + 4 authors+ 0 author

5 November 2022

Arginine methylation is a common post-translational modification affecting protein activity and the transcription of target genes when methylation occurs on histone tails. There are nine protein arginine methyltransferases (PRMTs) in mammals, divided...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
52 Citations
12,405 Views
20 Pages

Role of CAR T Cell Metabolism for Therapeutic Efficacy

  • Judit Rial Saborido,
  • Simon Völkl,
  • Michael Aigner,
  • Andreas Mackensen and
  • Dimitrios Mougiakakos

4 November 2022

Chimeric antigen receptor (CAR) T cells hold enormous potential. However, a substantial proportion of patients receiving CAR T cells will not reach long-term full remission. One of the causes lies in their premature exhaustion, which also includes a...

(This article belongs to the Section Tumor Microenvironment)
  • Systematic Review
  • Open Access
34 Citations
3,786 Views
12 Pages

Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review

  • Rodolfo Mauceri,
  • Martina Coppini,
  • Davide Vacca,
  • Giorgio Bertolazzi and ,
  • Vera Panzarella,
  • Olga Di Fede,
  • Claudio Tripodo and
  • Giuseppina Campisi
  • + 3 authors+ 0 author

4 November 2022

Background: Oral squamous cell carcinoma (OSCC) is one of the most prevalent cancers worldwide. Despite recent advances in diagnosis and treatment, in recent years, an increase in the incidence of OSCC has been registered, and the mortality rate is s...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
9 Citations
4,740 Views
12 Pages

Accurate Characterization of Bladder Cancer Cells with Intraoperative Flow Cytometry

  • Athanasios Paliouras,
  • Georgios S. Markopoulos,
  • Stavros Tsampalas,
  • Stefania Mantziou and ,
  • Ioannis Giannakis,
  • Dimitrios Baltogiannis,
  • Georgios K. Glantzounis,
  • George A. Alexiou,
  • Evangelia Lampri and
  • George Vartholomatos
  • + 6 authors+ 1 author

4 November 2022

Bladder cancer represents a major health issue. Transurethral resection is the first line treatment and an accurate assessment of tumor margins might warrant complete tumor removal. Genomic instability and proliferative potential are common hallmarks...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
38 Citations
7,929 Views
24 Pages

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy

  • Dhanashree Murugan,
  • Vasanth Murugesan,
  • Balaji Panchapakesan and
  • Loganathan Rangasamy

4 November 2022

Natural killer (NK) cells are one of the first lines of defense against infections and malignancies. NK cell-based immunotherapies are emerging as an alternative to T cell-based immunotherapies. Preclinical and clinical studies of NK cell-based immun...

(This article belongs to the Special Issue Natural Killer Cells in Cancer Biology and Therapy)
  • Article
  • Open Access
7 Citations
3,005 Views
17 Pages

4 November 2022

The molecular mechanism that promotes pancreatic cancer remains unclear, so it is important to find the molecular network of important genes related to pancreatic cancer. To find the key molecule of pancreatic cancer, differential gene expression ana...

(This article belongs to the Special Issue Signaling Pathway in Gastrointestinal Cancer)
  • Review
  • Open Access
22 Citations
5,015 Views
14 Pages

Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications

  • Andrianna Drosouni,
  • Maria Panagopoulou,
  • Vassilis Aidinis and
  • Ekaterini Chatzaki

4 November 2022

Autotaxin (ATX), the protein product of Ectonucleotide Pyrophosphatase Phosphodiesterase 2 (ENPP2), is a secreted lysophospholipase D (lysoPLD) responsible for the extracellular production of lysophosphatidic acid (LPA). ATX-LPA pathway signaling par...

(This article belongs to the Special Issue Liquid Biopsy in Breast Cancer)
  • Review
  • Open Access
44 Citations
7,157 Views
16 Pages

Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy

  • Alina A. Bagdasaryan,
  • Vladimir N. Chubarev,
  • Elena A. Smolyarchuk,
  • Vladimir N. Drozdov and ,
  • Ivan I. Krasnyuk,
  • Junqi Liu,
  • Ruitai Fan,
  • Edmund Tse,
  • Evgenia V. Shikh and
  • Olga A. Sukocheva
  • + 5 authors+ 0 author

4 November 2022

Breast cancer (BC) is the prevailing malignancy and major cause of cancer-related death in females. Doxorubicin is a part of BC neoadjuvant and adjuvant chemotherapy regimens. The administration of anthracycline derivates, such as doxorubicin, may ca...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
26 Citations
4,987 Views
22 Pages

Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials

  • Aisha Babi,
  • Karashash Menlibayeva,
  • Torekhan Bex,
  • Aidos Doskaliev and ,
  • Serik Akshulakov and
  • Maxim Shevtsov
  • + 1 author+ 0 author

4 November 2022

Heat shock proteins (HSPs) are conservative and ubiquitous proteins that are expressed both in prokaryotic and eukaryotic organisms and play an important role in cellular homeostasis, including the regulation of proteostasis, apoptosis, autophagy, ma...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
11 Citations
3,144 Views
15 Pages

CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma

  • Jichun Gu,
  • Yujie Guo,
  • Jiali Du,
  • Lei Kong and ,
  • Junyuan Deng,
  • Baian Tao,
  • Hengchao Li,
  • Chen Jin,
  • Deliang Fu and
  • Ji Li
  • + 5 authors+ 0 author

4 November 2022

(1) Background: Recently, cell division cycle associated 8 (CDCA8) was found to be overexpressed in pancreatic ductal adenocarcinoma (PDAC). Here, we aimed to explore the specific mechanism of action of CDCA8 in PDAC progression. (2) Methods: All hum...

(This article belongs to the Section Molecular Cancer Biology)
  • Perspective
  • Open Access
14 Citations
4,051 Views
9 Pages

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors

  • Camila B. Xavier,
  • Carlos Diego H. Lopes,
  • Beatriz M. Awni,
  • Eduardo F. Campos and ,
  • João Pedro B. Alves,
  • Anamaria A. Camargo,
  • Gabriela D. A. Guardia,
  • Pedro A. F. Galante and
  • Denis L. Jardim
  • + 4 authors+ 0 author

4 November 2022

Purpose: Solid tumors harboring tumor mutational burden (TMB) ≥10 mutations per megabase (mut/Mb) received agnostic approval for pembrolizumab. This work aims to analyze the somatic mutational profile’s influence on the outcomes of patients...

(This article belongs to the Special Issue Biomarkers in the Era of Precision Oncology)
  • Communication
  • Open Access
11 Citations
4,061 Views
13 Pages

Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions

  • Tarek Kammoun,
  • Elodie Prévot,
  • Chris Serrand,
  • Romain Perolat and ,
  • Hélène de Forges,
  • Nadine Houédé,
  • Jean-Paul Beregi and
  • Julien Frandon
  • + 3 authors+ 0 author

4 November 2022

Background: Percutaneous cryoablation with liquid nitrogen is a new technique being used in the treatment of some malignant tumors. Our objective was to assess its feasibility in the ablation of tumor lesions of various sizes and locations. Methods:...

(This article belongs to the Collection Advances in Diagnostic and Interventional Radiology in Oncology)
  • Review
  • Open Access
13 Citations
6,030 Views
13 Pages

Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma

  • Andrew B. Katims,
  • Peter A. Reisz,
  • Lucas Nogueira,
  • Hong Truong and ,
  • Andrew T. Lenis,
  • Eugene J. Pietzak,
  • Kwanghee Kim and
  • Jonathan A. Coleman
  • + 3 authors+ 0 author

4 November 2022

This review describes the current landscape of targeted therapies in urothelial carcinoma. The standard of care for advanced urothelial carcinoma patients remains platinum-based combination chemotherapy followed by immunotherapy. However, median over...

(This article belongs to the Special Issue Novel Targets and Approaches in Cancer Therapy)
  • Review
  • Open Access
73 Citations
12,842 Views
23 Pages

KRAS in NSCLC: State of the Art and Future Perspectives

  • Priscilla Cascetta,
  • Arianna Marinello,
  • Chiara Lazzari,
  • Vanesa Gregorc and ,
  • David Planchard,
  • Roberto Bianco,
  • Nicola Normanno and
  • Alessandro Morabito
  • + 3 authors+ 0 author

4 November 2022

In NSCLC, KRAS mutations occur in up to 30% of all cases, most frequently at codon 12 and 13. KRAS mutations have been linked to adenocarcinoma histology, positive smoking history, and Caucasian ethnicity, although differences have been described acr...

  • Article
  • Open Access
31 Citations
3,988 Views
22 Pages

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma

  • Antonella Ravaggi,
  • Davide Capoferri,
  • Laura Ardighieri,
  • Iacopo Ghini and ,
  • Federico Ferrari,
  • Chiara Romani,
  • Mattia Bugatti,
  • Laura Zanotti,
  • Stephanie Vrede and
  • Franco Odicino
  • + 10 authors+ 5 authors

3 November 2022

Histopathologic assessment of high-risk endometrial cancer (EC) suffers from intersubject variability and poor reproducibility. The pragmatic classification in four molecular subgroups helps to overcome these limits, showing a significant prognostic...

(This article belongs to the Special Issue Biomarkers in the Era of Precision Oncology)
  • Article
  • Open Access
31 Citations
3,901 Views
10 Pages

The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density

  • Chun-Wei Huang,
  • Sey-En Lin,
  • Song-Fong Huang,
  • Ming-Chin Yu and ,
  • Jui-Hsiang Tang,
  • Chi-Neu Tsai and
  • Heng-Yuan Hsu
  • + 2 authors+ 0 author

3 November 2022

The outcomes of patients with hepatocellular carcinoma (HCC) are unsatisfactory because of its high recurrence rate. The Vessels that encapsulate tumor clusters (VETC) pattern is a unique vascular structure. In this study, we investigated the clinica...

(This article belongs to the Special Issue Tumor Microenvironment in Primary Liver Cancer)
  • Article
  • Open Access
4 Citations
2,567 Views
10 Pages

An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma

  • Davide Seminati,
  • Eltjona Mane,
  • Stefano Ceola,
  • Gabriele Casati and ,
  • Pietro Putignano,
  • Mattia Garancini,
  • Andrea Gatti,
  • Davide Leni,
  • Angela Ida Pincelli and
  • Fabio Pagni
  • + 7 authors+ 2 authors

3 November 2022

Incidental thyroid carcinomas (ITCs) are a fairly frequent finding in daily routine practice, with papillary thyroid microcarcinoma being the most frequent entity. In our work, we isolated incidental cases arising in thyroids removed for other cytolo...

(This article belongs to the Special Issue Thyroid Cancer Surgery: Recent Advances and Future Directions)
  • Article
  • Open Access
13 Citations
3,022 Views
15 Pages

Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments

  • Sylvia A. van Laar,
  • Ellen Kapiteijn,
  • Kim B. Gombert-Handoko,
  • Henk-Jan Guchelaar and
  • Juliette Zwaveling

3 November 2022

Introduction: Nivolumab (N), pembrolizumab (P), and dabrafenib plus trametinib (D + T) have been registered as adjuvant treatments for resected stage III and IV melanoma since 2018. Electronic health records (EHRs) are a real-world data source that c...

(This article belongs to the Section Cancer Pathophysiology)
  • Review
  • Open Access
40 Citations
7,118 Views
35 Pages

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer

  • Takahito Kawano,
  • Junichi Inokuchi,
  • Masatoshi Eto,
  • Masaharu Murata and
  • Jeong-Hun Kang

3 November 2022

Protein kinase C (PKC) is a large family of calcium- and phospholipid-dependent serine/threonine kinases that consists of at least 11 isozymes. Based on their structural characteristics and mode of activation, the PKC family is classified into three...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
40 Citations
7,632 Views
18 Pages

Generalization of Deep Learning in Digital Pathology: Experience in Breast Cancer Metastasis Detection

  • Sofia Jarkman,
  • Micael Karlberg,
  • Milda Pocevičiūtė,
  • Anna Bodén and ,
  • Péter Bándi,
  • Geert Litjens,
  • Claes Lundström,
  • Darren Treanor and
  • Jeroen van der Laak
  • + 4 authors+ 0 author

3 November 2022

Poor generalizability is a major barrier to clinical implementation of artificial intelligence in digital pathology. The aim of this study was to test the generalizability of a pretrained deep learning model to a new diagnostic setting and to a small...

(This article belongs to the Special Issue Image Analysis and Computational Pathology in Cancer Diagnosis)

of 7

XFacebookLinkedIn
Cancers - ISSN 2072-6694